InvestorNewsBreaks – BioAdaptives, Inc. (BDPT) Appoints Car Rental Industry Veteran to Its Board of Directors

BioAdaptives (OTC: BDPT), a leader in the health and wellness sector, is announcing the appointment of Gimhana Dissanayake to its Board of Directors. According to the announcement, Gimhana brings over two decades of comprehensive experience and a proven track record of strategic growth and operational excellence to the company. He currently serves as the vice president of operational sales for North America at The Hertz Corporation (NYSE: HTZ). With an illustrious career that has spanned various leadership positions at Hertz, Gimhana is renowned for his strategic vision and leadership acumen. The announcement noted that his educational background and extensive professional experience make him an invaluable addition to the BioAdaptives board. “We are delighted to welcome Gimhana to our Board of Directors,” said Jim Keener, chairman of the board at BioAdaptives. “His exceptional contributions to the car rental industry and his strategic insight are precisely what BioAdaptives need as we continue to innovate and expand our reach in the wellness sector. We are confident that Gimhana’s leadership will significantly enrich our board’s talent and expertise, propelling us to new heights.”

To view the full press release, visit https://ibn.fm/bZF5C

About BioAdaptives, Inc.

BioAdaptives, Inc. develops and distributes natural herbal-based products that improve health and wellness for humans and animals, with an emphasis on optimizing pain relief, antiviral activity, and immune system defense; stress resistance; endurance; recovery from injury, illness, and exercise; and anti-aging properties. The company’s current dietary supplement formulations are carefully selected from the best sources worldwide, and proprietary methods are utilized to enhance the bioavailability of nutrients. BioAdaptives’ products for horses and dogs have also demonstrated increased general health, competitive performance enhancement, rejuvenation effects, pain relief and improved appearance. For more information about the company, visit www.shopbioadaptives.com.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
Editor@InvestorWire.com

InvestorWire is powered by IBN

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.